Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1383.00
6.75 (0.49%)
< Home < Back

Cipla - Quaterly Results

Date: 25-07-2025
The Revenue for the quarter ended  June 2025 of Rs. 50461.70 millions grew by 12.11 % from Rs. 45010.50 millions.Profit saw a slight increase of 23.41%to Rs. 13031.30  millions from Rs. 10559.40 millions.Operating Profit saw a handsome growth to 18955.20 millions from 15733.80 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 50461.70 45010.50 12.11 50461.70 45010.50 12.11 190448.50 165743.40 14.91
Other Income 2710.70 2135.20 26.95 2710.70 2135.20 26.95 9847.20 10706.60 -8.03
PBIDT 18955.20 15733.80 20.47 18955.20 15733.80 20.47 67631.60 55548.10 21.75
Interest 58.80 50.70 15.98 58.80 50.70 15.98 151.10 202.50 -25.38
PBDT 18896.40 15683.10 20.49 18896.40 15683.10 20.49 70427.10 55345.60 27.25
Depreciation 1456.90 1378.60 5.68 1456.90 1378.60 5.68 5738.90 5875.90 -2.33
PBT 17439.50 14304.50 21.92 17439.50 14304.50 21.92 64688.20 49469.70 30.76
TAX 4408.20 3745.10 17.71 4408.20 3745.10 17.71 13111.70 12327.80 6.36
Deferred Tax -152.20 165.90 -191.74 -152.20 165.90 -191.74 -491.50 60.90 -907.06
PAT 13031.30 10559.40 23.41 13031.30 10559.40 23.41 51576.50 37141.90 38.86
Equity 1615.50 1615.00 0.03 1615.50 1615.00 0.03 1615.20 1614.70 0.03
PBIDTM(%) 37.56 34.96 7.46 37.56 34.96 7.46 35.51 33.51 5.96